Avid Bioservices Inc (CDMO)

[pphmtoolong]

The Sunrise trial was Peregrine's ticket to near term success. Either as a go it alone company or as part of lucrative partnership. It didn't happen. It doesn't really matter why.

The only question worth asking is how Peregrine can go forward with very limited financing resources available.

We need to hear a concrete action plan at the CC. Analysis of the failed Sunrise is not likely to do anything to improve Peregrine prospects for future success IMO.

Peregrine management has to realize there is no time or money to waste. Cost cutting must be quick and painful. A partner willing to front Bavi-immuno trials must be found in a matter of months.

If a partner cannot be found in short order, the company will run out of money. At that point all that's left is Avid. Could be worse, I guess.

Paul